EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients ...

India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...

St. Luke’s Medical Center (SLMC) has opened an inhaler clinic service specifically designed to cater to patients with ...

Patients with chronic obstructive pulmonary disease (COPD) that is in a state of disease stability (DS) have fewer exacerbations and lower mortality, according to study findings published in Chest.

Using coronary artery calcium scores alongside cardiovascular risk scores better identifies patients with chronic obstructive pulmonary disease at a high risk for major adverse cardiovascular events.

In both adults with and without self-reported COPD, a 6- or 12-week course of cytisinicline helped more daily smokers achieve ...

In an analysis adjusted for tobacco cigarette use, the likelihood for asthma and COPD significantly rose with daily cannabis ...

ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients Glasmacinal, a novel macrolide, was well tolerated and reduced neutrophilic inflammation in COPD patients ...

A shock survey by charity Asthma + Lung UK reveals that more than 90% of people with COPD are receiving inadequate care ...

A mum-of-five who has lived with asthma since she was four months old and now battles COPD faces insults from strangers in ...

By Dennis Thompson HealthDay ReporterMONDAY, Dec. 8, 2025 (HealthDay News) — Discharging hospital patients early to recover ...

The toxic haze that blanketed large parts of India in November didn’t just cloud the skies—it pushed sales of asthma and COPD medicines to their highest levels in three years.